Zhihui Wang

2.4k total citations
47 papers, 1.3k citations indexed

About

Zhihui Wang is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Zhihui Wang has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Infectious Diseases. Recurrent topics in Zhihui Wang's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (8 papers) and COVID-19 Clinical Research Studies (7 papers). Zhihui Wang is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (8 papers) and COVID-19 Clinical Research Studies (7 papers). Zhihui Wang collaborates with scholars based in China, Australia and Switzerland. Zhihui Wang's co-authors include Ping Yin, Danying Liao, Jun Deng, Liqiong Cai, Min Xu, Heng Mei, Hongbo Wang, Yu Hu, Yong Gao and Lu Tang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Zhihui Wang

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhihui Wang China 16 501 358 231 226 206 47 1.3k
Yan Ding China 18 447 0.9× 409 1.1× 273 1.2× 193 0.9× 227 1.1× 58 1.4k
Mahmood Yaseen Hachim United Arab Emirates 22 323 0.6× 501 1.4× 281 1.2× 173 0.8× 137 0.7× 101 1.4k
Rami M. Elshazli Egypt 18 407 0.8× 273 0.8× 190 0.8× 101 0.4× 178 0.9× 65 1.1k
Limin Duan China 15 303 0.6× 366 1.0× 212 0.9× 142 0.6× 90 0.4× 36 1.1k
Jie Ren China 18 354 0.7× 474 1.3× 195 0.8× 235 1.0× 154 0.7× 55 1.4k
Masataka Nishiga Japan 14 562 1.1× 418 1.2× 188 0.8× 171 0.8× 330 1.6× 27 1.6k
Chenxi Liu China 18 366 0.7× 267 0.7× 199 0.9× 87 0.4× 207 1.0× 94 1.5k
James D. McFadyen Australia 19 334 0.7× 390 1.1× 215 0.9× 78 0.3× 221 1.1× 69 1.8k
Xueqin Chen China 24 241 0.5× 462 1.3× 304 1.3× 196 0.9× 90 0.4× 156 1.8k
Jinpeng Li China 20 173 0.3× 678 1.9× 232 1.0× 299 1.3× 104 0.5× 77 1.5k

Countries citing papers authored by Zhihui Wang

Since Specialization
Citations

This map shows the geographic impact of Zhihui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihui Wang more than expected).

Fields of papers citing papers by Zhihui Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihui Wang. The network helps show where Zhihui Wang may publish in the future.

Co-authorship network of co-authors of Zhihui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihui Wang. A scholar is included among the top collaborators of Zhihui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihui Wang. Zhihui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Fangfang, Lin Gan, Guiping Wan, et al.. (2025). Serum 2-miRNA panel as a non-invasive diagnostic biomarker for adenomyosis. Gene. 970. 149777–149777.
2.
Wang, Zhihui, Hao Zhou, Lie Zhang, Xin Liu, & Hui Wang. (2025). Identification and validation of MMP1 as a biomarker associated with mitochondrial oxidative stress in liver hepatocellular carcinoma. Scientific Reports. 15(1). 24276–24276.
3.
Zhang, Zichao, Chenglong Wang, Wenzheng Shi, Zhihui Wang, & Weihua Fu. (2024). Construction of store-operated calcium entry-related gene signature for predicting prognosis and indicates immune microenvironment infiltration in stomach adenocarcinomas. Scientific Reports. 14(1). 22342–22342. 1 indexed citations
4.
Wang, Zhihui, Xiaowen Bai, Mengdi Wang, et al.. (2024). Risk factors for diabetic retinopathy in young and middle-aged patients: a retrospective study. BMC Ophthalmology. 24(1). 544–544. 2 indexed citations
5.
Lin, Aiping, Mingxia Wang, Zhihui Wang, et al.. (2024). Expression and relationship of PD-L1, CD24, and CD47 in hepatitis B virus associated hepatocellular carcinoma. Scientific Reports. 14(1). 31530–31530. 1 indexed citations
6.
Pan, Xuebiao, Mei Qin, Rui Cao, et al.. (2024). The Short-Term Responses of Forest Soil Invertebrate Communities to Typhoon Disturbances. Forests. 15(4). 583–583. 1 indexed citations
7.
Tan, Xueyun, Sufei Wang, Hebing Chen, et al.. (2023). Prognosis prediction of icotinib as targeted therapy for advanced EGFR-positive non–small cell lung cancer patients. Investigational New Drugs. 41(3). 463–472. 2 indexed citations
8.
Xiao, Wenjing, Qi Huang, Ping Luo, et al.. (2023). Lipid metabolism of plasma-derived small extracellular vesicles in COVID-19 convalescent patients. Scientific Reports. 13(1). 16642–16642. 4 indexed citations
9.
Hu, Bowen, Jie Gao, Jihua Shi, et al.. (2022). Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma. Frontiers in Immunology. 13. 970117–970117. 6 indexed citations
10.
Wang, Zhihui, et al.. (2022). Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors. Journal of Environmental Pathology Toxicology and Oncology. 42(2). 11–30. 2 indexed citations
11.
Liu, Xin, et al.. (2022). A pan-cancer analysis reveals the genetic alterations and immunotherapy of Piezo2 in human cancer. Frontiers in Genetics. 13. 918977–918977. 8 indexed citations
12.
Lin, Zhuoying, Wenjie Huang, Qin He, et al.. (2021). FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter. Journal of Experimental & Clinical Cancer Research. 40(1). 50–50. 51 indexed citations
13.
Liao, Danying, Fen Zhou, Lili Luo, et al.. (2020). Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. The Lancet Haematology. 7(9). e671–e678. 328 indexed citations
14.
Zhang, Shuai, Mengfei Guo, Feng Wu, et al.. (2020). Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study. Clinical Microbiology and Infection. 26(12). 1670–1675. 23 indexed citations
15.
16.
He, Qin, Zhuoying Lin, Zhihui Wang, et al.. (2020). SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET. Oncogene. 39(50). 7279–7295. 40 indexed citations
17.
Wang, Zhihui, et al.. (2019). miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1. Cancer Cell International. 19(1). 115–115. 23 indexed citations
18.
Li, Hongyu, Zhihui Wang, Zhen Fu, et al.. (2018). Associations between blood cadmium levels and cognitive function in a cross-sectional study of US adults aged 60 years or older. BMJ Open. 8(4). e020533–e020533. 64 indexed citations
19.
Liu, Yanfang, Ying Liu, Juanjuan Guo, et al.. (2017). Genetic polymorphism of 29 STR loci in the Hunan Han population from China. Forensic Sciences Research. 4(4). 351–353. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Ding Breakdown of academic impact, for papers by Mahmood Yaseen Hachim Breakdown of academic impact, for papers by Rami M. Elshazli Breakdown of academic impact, for papers by Limin Duan Breakdown of academic impact, for papers by Jie Ren Breakdown of academic impact, for papers by Masataka Nishiga Breakdown of academic impact, for papers by Chenxi Liu Breakdown of academic impact, for papers by James D. McFadyen Breakdown of academic impact, for papers by Xueqin Chen Breakdown of academic impact, for papers by Jinpeng Li
Rankless by CCL
2026